Cooperation of cancer stem cell properties and epithelial-mesenchymal transition in the establishment of breast cancer metastasis.
Epithelial-mesenchymal transition (EMT) is a multistep process in which cells acquire molecular alterations such as loss of cell-cell junctions and restructuring of the cytoskeleton. There is an increasing understanding that this process may promote breast cancer progression through promotion of invasive and metastatic tumor growth. Recent observations imply that there may be a cross-talk between EMT and cancer stem cell properties, leading to enhanced tumorigenicity and the capacity to generate heterogeneous tumor cell populations. Here, we review the experimental and clinical evidence for the involvement of EMT in cancer stem cell theory, focusing on the common characteristics of this phenomenon.
Department of Surgery, Keio University School of Medicine, 35 Shinanomachi, Shinjyuku, Tokyo 160-8582, Japan.
Tetsu
T
Hayashida
Hiromitsu
H
Jinno
Yuko
Y
Kitagawa
Masaki
M
Kitajima
Cancer Epidemiol Biomarkers Prev. 2010 Feb;19(2):327-37
20142235
Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3983-8
12629218
Cell Stem Cell. 2007 Nov;1(5):555-67
18371393
Cancer Res. 2009 Sep 15;69(18):7135-9
19738043
Cancer Res. 2007 Sep 15;67(18):8643-52
17875704
Clin Cancer Res. 2006 Jul 15;12(14 Pt 1):4147-53
16857785
Lab Invest. 1991 Sep;65(3):262-71
1890806
Breast Cancer Res Treat. 2009 Jun;115(3):581-90
18679793
Cell Cycle. 2004 Dec;3(12):1477-80
15539952
Cell Stem Cell. 2010 Jul 2;7(1):51-63
20621050
Cell. 2008 May 16;133(4):704-15
18485877
Stem Cell Rev. 2007 Jan;3(1):18-29
17873378
Breast Cancer Res. 2006;8(5):R59
17062128
Mol Cancer Res. 2009 Mar;7(3):330-8
19276181
Lab Invest. 2007 Dec;87(12):1218-26
17922020
Cell. 1994 Oct 21;79(2):185-8
7525076
Clin Cancer Res. 2008 Aug 15;14(16):5013-21
18698019
Arch Oral Biol. 2004 Sep;49(9):675-89
15275855
Nature. 2008 Apr 3;452(7187):650-3
18385740
Genes Dev. 2004 May 15;18(10):1131-43
15155580
Acta Anat (Basel). 1995;154(1):8-20
8714286
Curr Opin Genet Dev. 1992 Aug;2(4):556-61
1525507
Cell. 2009 Aug 21;138(4):645-659
19682730
Cancer Res. 1999 Jan 1;59(1):8-13
9892175
Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15665-70
9861027
Cancer Res. 2008 Feb 15;68(4):989-97
18281472
Nature. 2007 Dec 20;450(7173):1235-9
18097410
Blood. 1998 Sep 15;92(6):2041-52
9731062
Oncogene. 2004 Sep 20;23(43):7274-82
15378087
J Natl Cancer Inst. 2008 May 7;100(9):672-9
18445819
Int J Oncol. 2009 May;34(5):1201-7
19360333
Annu Rev Med. 2007;58:267-84
17002552
Pathology. 2007 Jun;39(3):305-18
17558857
Nature. 2009 Jan 29;457(7229):608-11
19092804
FASEB J. 1994 Apr 1;8(6):401-7
7513289
Int J Oncol. 2007 Aug;31(2):277-83
17611683
Breast Cancer Res. 2000;2(2):125-32
11250702
J Clin Invest. 1999 Jan;103(2):197-206
9916131
Cells Tissues Organs. 2007;185(1-3):191-203
17587825
Nat Med. 1997 Jul;3(7):730-7
9212098
Clin Cancer Res. 2003 Aug 1;9(8):3052-7
12912956
Cancer Res. 2007 Mar 1;67(5):1979-87
17332325
Cancer Res. 2005 Oct 15;65(20):9455-62
16230409
J Hematother. 1994 Fall;3(3):165-73
7530132
Cancer Cell. 2007 Mar;11(3):259-73
17349583
Clin Cancer Res. 2007 Sep 1;13(17):5001-9
17785550
Proc Natl Acad Sci U S A. 2009 Aug 18;106(33):13820-5
19666588
J Cell Physiol. 2007 Nov;213(2):374-83
17680632
Cancer Res. 2005 Jul 15;65(14):5991-5; discussion 5995
16024595
Proc Natl Acad Sci U S A. 2010 Jan 19;107(3):1100-5
20080567
Mol Cell Biol. 2001 Dec;21(23):8184-8
11689706
Cell. 2008 Jul 25;134(2):215-30
18662538
Nat Rev Genet. 2005 Dec;6(12):893-904
16341070
Stem Cells. 2006 Mar;24(3):506-13
16239320
Proc Natl Acad Sci U S A. 2004 Sep 28;101(39):14228-33
15381773
Nat Rev Cancer. 2002 Jun;2(6):442-54
12189386
Blood. 1998 Apr 1;91(7):2272-82
9516125
Breast Cancer Res. 2009;11(4):R46
19589136
Cells Tissues Organs. 2007;185(1-3):7-19
17587803
Cell. 2009 Nov 25;139(5):871-90
19945376
Nat Rev Cancer. 2005 Sep;5(9):744-9
16148886
Nature. 2007 Oct 25;449(7165):1003-7
17934449
J Cell Biol. 2006 Mar 27;172(7):973-81
16567498
Development. 1990 Dec;110(4):1271-84
2151613
Cancer Res. 2008 Feb 1;68(3):937-45
18245497
J Clin Invest. 2003 Dec;112(12):1776-84
14679171
Cell Cycle. 2010 Jun 15;9(12):2363-74
20519943
Nat Rev Cancer. 2002 Aug;2(8):563-72
12154349
Proc Natl Acad Sci U S A. 2010 Aug 31;107(35):15449-54
20713713
Nat Cell Biol. 2009 Nov;11(11):1287-96
19838175
N Engl J Med. 2008 Jul 24;359(4):366-77
18596266
Cancer Res. 2010 Aug 15;70(16):6619-28
20682801
Cancer. 1997 Oct 15;80(8 Suppl):1529-37
9362419
Clin Cancer Res. 2010 Jan 1;16(1):45-55
20028757
Cancer Sci. 2010 Jul;101(7):1731-7
20384634
N Engl J Med. 2007 Jan 18;356(3):217-26
17229949
Oncogene. 2006 Jun 8;25(24):3408-23
16186809
Nat Rev Cancer. 2009 Apr;9(4):265-73
19262571
Am J Pathol. 2002 Nov;161(5):1881-91
12414534
Nature. 2002 Aug 22;418(6900):823
12192390
Clin Cancer Res. 2005 Feb 1;11(3):1154-9
15709183